These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
334 related items for PubMed ID: 17643417
1. Cannabinoid CB(2) receptor activation prevents bronchoconstriction and airway oedema in a model of gastro-oesophageal reflux. Cui YY, D'Agostino B, Risse PA, Marrocco G, Naline E, Zhang Y, Chen HZ, Finance O, Rinaldi-Carmona M, Rossi F, Advenier C. Eur J Pharmacol; 2007 Nov 14; 573(1-3):206-13. PubMed ID: 17643417 [Abstract] [Full Text] [Related]
2. The cannabinoid receptor agonist WIN 55212-2 inhibits neurogenic inflammations in airway tissues. Yoshihara S, Morimoto H, Ohori M, Yamada Y, Abe T, Arisaka O. J Pharmacol Sci; 2005 May 14; 98(1):77-82. PubMed ID: 15888960 [Abstract] [Full Text] [Related]
7. The cannabinoid receptor agonist WIN 55,212-2 inhibits antigen-induced plasma extravasation in guinea pig airways. Fukuda H, Abe T, Yoshihara S. Int Arch Allergy Immunol; 2010 May 14; 152(3):295-300. PubMed ID: 20150748 [Abstract] [Full Text] [Related]
8. Inhibition of interleukin-8 release in the human colonic epithelial cell line HT-29 by cannabinoids. Ihenetu K, Molleman A, Parsons ME, Whelan CJ. Eur J Pharmacol; 2003 Jan 01; 458(1-2):207-15. PubMed ID: 12498928 [Abstract] [Full Text] [Related]
10. First in vivo evidence for a functional interaction between chemokine and cannabinoid systems in the brain. Benamar K, Geller EB, Adler MW. J Pharmacol Exp Ther; 2008 May 01; 325(2):641-5. PubMed ID: 18281594 [Abstract] [Full Text] [Related]
11. CB1 receptor activation in the basolateral amygdala produces antinociception in animal models of acute and tonic nociception. Hasanein P, Parviz M, Keshavarz M, Javanmardi K. Clin Exp Pharmacol Physiol; 2007 May 01; 34(5-6):439-49. PubMed ID: 17439413 [Abstract] [Full Text] [Related]
12. Pharmacological characterisation of cannabinoid receptors inhibiting interleukin 2 release from human peripheral blood mononuclear cells. Ihenetu K, Molleman A, Parsons M, Whelan C. Eur J Pharmacol; 2003 Mar 19; 464(2-3):207-15. PubMed ID: 12620515 [Abstract] [Full Text] [Related]
15. Characterization of cannabinoid modulation of sensory neurotransmission in the rat isolated mesenteric arterial bed. Duncan M, Kendall DA, Ralevic V. J Pharmacol Exp Ther; 2004 Oct 19; 311(1):411-9. PubMed ID: 15205450 [Abstract] [Full Text] [Related]
16. R+-methanandamide inhibits tracheal response to endogenously released acetylcholine via capsazepine-sensitive receptors. Nieri P, Martinotti E, Testai L, Adinolfi B, Calderone V, Breschi MC. Eur J Pharmacol; 2003 Jan 10; 459(1):75-81. PubMed ID: 12505536 [Abstract] [Full Text] [Related]
19. Evidence for both inverse agonism at the cannabinoid CB1 receptor and the lack of an endogenous cannabinoid tone in the rat and guinea-pig isolated ileum myenteric plexus-longitudinal muscle preparation. Makwana R, Molleman A, Parsons ME. Br J Pharmacol; 2010 Jun 10; 160(3):615-26. PubMed ID: 20590566 [Abstract] [Full Text] [Related]
20. Modulation of cytokine responses in Corynebacterium parvum-primed endotoxemic mice by centrally administered cannabinoid ligands. Smith SR, Terminelli C, Denhardt G. Eur J Pharmacol; 2001 Aug 03; 425(1):73-83. PubMed ID: 11672577 [Abstract] [Full Text] [Related] Page: [Next] [New Search]